Bristol-Myers Squibb Company
BMY
$66.58
-$0.37-0.55%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.91% | 146.27% | -50.61% | 68.02% | -46.66% |
| Total Depreciation and Amortization | 0.00% | -40.33% | -2.48% | 6.06% | -2.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -86.31% | -57.15% | 30,240.00% | -99.69% | 350.00% |
| Change in Net Operating Assets | 77.98% | -71.34% | -154.14% | 20,266.67% | 100.80% |
| Cash from Operations | 207.34% | -44.07% | -68.72% | 61.12% | 100.46% |
| Capital Expenditure | 12.10% | 6.22% | -15.63% | 11.36% | -38.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -40.00% | 96.19% | 8.91% | -557.54% | -265.38% |
| Divestitures | -33.01% | 11.83% | 0.00% | 3.33% | 11.11% |
| Other Investing Activities | -4,503.23% | -109.12% | 59.62% | 319.59% | 75.99% |
| Cash from Investing | -1,132.06% | 91.02% | 14.34% | -259.83% | 5.21% |
| Total Debt Issued | -140.50% | -93.98% | 106,580.00% | -91.38% | -84.24% |
| Total Debt Repaid | -144.00% | 95.03% | -4,296.51% | 64.39% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.31% | -1.66% | 0.08% | -0.08% | -0.32% |
| Other Financing Activities | 107.14% | -196.97% | -1,000.00% | -127.27% | 110.68% |
| Cash from Financing | -68.59% | 74.13% | -304.63% | 18.85% | -84.89% |
| Foreign Exchange rate Adjustments | 79.17% | -1,060.00% | 225.00% | -103.13% | 93.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.59% | 88.47% | -276.82% | 79.44% | 228.79% |